GeneCentric Therapeutics, Inc. — Form D

GeneCentric Therapeutics, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-20. The offering totals $5.0M, of which $2.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Don HardisonDirectorDurham, NC
MYLA LAI-GOLDMANDirectorDurham, NC
ARNOLD LEVINEDirectorDurham, NC
MICHAEL MILBURNDirectorDurham, NC
CHARLES PEROUDirectorDurham, NC
Prasanth ReddyDirectorDurham, NC
Clay ThorpDirectorDurham, NC
MICHAEL MILBURNExecutive OfficerDurham, NC
Ellen LubmanDirectorMorristown, NJ
CHARLES PEROUExecutive OfficerDurham, NC
MYLA LAI-GOLDMANExecutive OfficerDurham, NC
Ellen V LubmanDirectorDurham, NC
Michael V MilburnDirectorDurham, NC
Michael V MilburnExecutive OfficerDurham, NC
Perou V CharlesDirectorDurham, NC
Perou V CharlesExecutive OfficerDurham, NC
Clay V ThorpDirectorDurham, NC
Myla V Lai-GoldmanDirectorDurham, NC
Myla V Lai-GoldmanExecutive OfficerDurham, NC
Arnold V LevineDirectorDurham, NC
Clay Neil ThorpDirectorDurham, NC
Arnold Neil LevineDirectorDurham, NC
David Neil HayesDirectorDurham, NC
David Neil HayesExecutive OfficerDurham, NC
Charles Neil PerouDirectorDurham, NC

Other filings by this issuer (7)

FiledFormOfferingSold
2022-09-20D$3.5M$2.5M
2021-10-07D$7.5M$4.5M
2021-01-13D$1.2M$1.2M
2017-01-05D$8.6M$6.1M
2014-07-11D/A$5.0M$5.0M
2013-07-02D$5.0M$2.5M
2011-09-16D$250K$250K

More